Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide added to metformin in coronary artery disease with newly diagnosed type 2 diabetes
2011-005405-78Phase 4Completed
- Sponsor
- Steen Bendix Haugaard
- Start
- Jan 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), coronary arteriosclerosis, sponsored by Steen Bendix Haugaard. Started Jan 2012; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)coronary arteriosclerosis
Beyond the preview
Go deeper on 2011-005405-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005405-78.